Loading...

Mediterranean Towers

OTCPK:MDTW.F
Snowflake Description

Fair value with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MDTW.F
OTCPK
₪958M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Mediterranean Towers Ltd. operates a chain of retirement communities in Israel. The last earnings update was 29 days ago. More info.


Add to Portfolio Compare Print
MDTW.F Share Price and Events
7 Day Returns
0%
OTCPK:MDTW.F
-5.7%
US Healthcare
0.5%
US Market
1 Year Returns
-
OTCPK:MDTW.F
-0.6%
US Healthcare
8%
US Market
MDTW.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Mediterranean Towers (MDTW.F) 0% 0% 0% - - -
US Healthcare -5.7% -6.1% -6.3% -0.6% 16.7% 65.3%
US Market 0.5% 2.8% 12.2% 8% 39.1% 46.7%
1 Year Return vs Industry and Market
  • No trading data on MDTW.F.
  • No trading data on MDTW.F.
Price Volatility
MDTW.F
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for Mediterranean Towers's competitors could be found in our database.

MDTW.F Value

 Is Mediterranean Towers undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Mediterranean Towers to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Mediterranean Towers.

OTCPK:MDTW.F Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 8.5%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:MDTW.F
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.72
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.719 (1 + (1- 23%) (43.96%))
0.975
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.98
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.975 * 5.96%)
8.54%

Discounted Cash Flow Calculation for OTCPK:MDTW.F using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Mediterranean Towers is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

OTCPK:MDTW.F DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (ILS, Millions) Source Present Value
Discounted (@ 8.54%)
2019 118.98 Est @ -27.35% 109.62
2020 97.18 Est @ -18.32% 82.49
2021 85.51 Est @ -12.01% 66.87
2022 79.02 Est @ -7.59% 56.93
2023 75.47 Est @ -4.49% 50.10
2024 73.72 Est @ -2.32% 45.08
2025 73.12 Est @ -0.81% 41.20
2026 73.31 Est @ 0.25% 38.05
2027 74.04 Est @ 1% 35.41
2028 75.16 Est @ 1.52% 33.12
Present value of next 10 years cash flows ₪558.86
OTCPK:MDTW.F DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= ₪75.16 × (1 + 2.73%) ÷ (8.54% – 2.73%)
₪1,328.69
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ₪1,328.69 ÷ (1 + 8.54%)10
₪585.44
OTCPK:MDTW.F Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ₪558.86 + ₪585.44
₪1,144.30
Equity Value per Share
(ILS)
= Total value / Shares Outstanding
= ₪1,144.30 / 143.30
₪7.99
OTCPK:MDTW.F Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in OTCPK:MDTW.F represents 0.25211x of TASE:MDTR
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.25211x
Value per Share
(Listing Adjusted, USD)
= Value per Share (ILS) x Listing Adjustment Factor
= ₪ 7.99 x 0.25211
$2.01
Value per share (USD) From above. $2.01
Current discount Discount to share price of $1.68
= -1 x ($1.68 - $2.01) / $2.01
16.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Mediterranean Towers is available for.
Intrinsic value
16%
Share price is $1.68 vs Future cash flow value of $2.01
Current Discount Checks
For Mediterranean Towers to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Mediterranean Towers's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • Mediterranean Towers's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Mediterranean Towers's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Mediterranean Towers's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:MDTW.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in ILS ₪0.44
TASE:MDTR Share Price ** TASE (2019-01-16) in ILS ₪6.68
United States of America Healthcare Industry PE Ratio Median Figure of 53 Publicly-Listed Healthcare Companies 22.95x
United States of America Market PE Ratio Median Figure of 3,072 Publicly-Listed Companies 18.22x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Mediterranean Towers.

OTCPK:MDTW.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TASE:MDTR Share Price ÷ EPS (both in ILS)

= 6.68 ÷ 0.44

15.24x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Mediterranean Towers is good value based on earnings compared to the US Healthcare industry average.
  • Mediterranean Towers is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does Mediterranean Towers's expected growth come at a high price?
Raw Data
OTCPK:MDTW.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 15.24x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
15.9%per year
United States of America Healthcare Industry PEG Ratio Median Figure of 40 Publicly-Listed Healthcare Companies 1.59x
United States of America Market PEG Ratio Median Figure of 2,105 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Mediterranean Towers, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Mediterranean Towers's assets?
Raw Data
OTCPK:MDTW.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in ILS ₪5.62
TASE:MDTR Share Price * TASE (2019-01-16) in ILS ₪6.68
United States of America Healthcare Industry PB Ratio Median Figure of 93 Publicly-Listed Healthcare Companies 2.42x
United States of America Market PB Ratio Median Figure of 5,177 Publicly-Listed Companies 1.94x
OTCPK:MDTW.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TASE:MDTR Share Price ÷ Book Value per Share (both in ILS)

= 6.68 ÷ 5.62

1.19x

* Primary Listing of Mediterranean Towers.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Mediterranean Towers is good value based on assets compared to the US Healthcare industry average.
X
Value checks
We assess Mediterranean Towers's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Mediterranean Towers has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

MDTW.F Future Performance

 How is Mediterranean Towers expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Mediterranean Towers, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
15.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Mediterranean Towers expected to grow at an attractive rate?
  • Mediterranean Towers's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Mediterranean Towers's earnings growth is expected to exceed the United States of America market average.
  • Unable to compare Mediterranean Towers's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:MDTW.F Future Growth Rates Data Sources
Data Point Source Value (per year)
OTCPK:MDTW.F Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 15.9%
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 13.1%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 7.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:MDTW.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in ILS Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:MDTW.F Past Financials Data
Date (Data in ILS Millions) Revenue Cash Flow Net Income *
2018-12-31 175 167 63
2018-09-30 171 215 46
2018-06-30 165 229 63
2018-03-31 161 226 78
2017-12-31 155 249 90
2017-09-30 149 286 103
2017-06-30 143 242 82
2017-03-31 137 218 122
2016-12-31 131 158 126
2016-09-30 128 57 161
2016-06-30 126 72 153
2016-03-31 124 69 98

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Mediterranean Towers's earnings are expected to grow by 15.9% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Mediterranean Towers is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:MDTW.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Mediterranean Towers Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:MDTW.F Past Financials Data
Date (Data in ILS Millions) EPS *
2018-12-31 0.44
2018-09-30 0.32
2018-06-30 0.43
2018-03-31 0.58
2017-12-31 0.63
2017-09-30 0.71
2017-06-30 0.57
2017-03-31 0.87
2016-12-31 0.88
2016-09-30 1.14
2016-06-30 1.06
2016-03-31 0.69

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Mediterranean Towers will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Mediterranean Towers's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Mediterranean Towers has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

MDTW.F Past Performance

  How has Mediterranean Towers performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Mediterranean Towers's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Mediterranean Towers's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
  • Mediterranean Towers's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Mediterranean Towers's 1-year earnings growth is negative, it can't be compared to the US Healthcare industry average.
Earnings and Revenue History
Mediterranean Towers's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Mediterranean Towers Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:MDTW.F Past Revenue, Cash Flow and Net Income Data
Date (Data in ILS Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 174.51 62.73 39.44
2018-09-30 170.71 45.59 39.47
2018-06-30 165.35 62.86 42.18
2018-03-31 160.92 77.95 40.54
2017-12-31 155.45 89.91 44.24
2017-09-30 148.53 102.63 43.26
2017-06-30 142.52 81.67 41.93
2017-03-31 136.53 122.10 41.72
2016-12-31 131.08 125.64 39.47
2016-09-30 127.69 161.16 39.22
2016-06-30 125.82 152.67 38.35
2016-03-31 123.87 97.89 38.37
2015-12-31 122.85 103.60 36.44
2015-09-30 121.56 49.74 36.55
2015-06-30 120.99 47.41 35.36
2015-03-31 120.44 51.84 33.03
2014-12-31 119.91 14.38 30.61
2014-09-30 119.46 -9.72 26.94
2014-06-30 118.44 60.13 28.07
2014-03-31 117.22 64.40 27.79
2013-12-31 116.26 75.27 28.30
2013-09-30 115.52 97.77 29.72
2012-12-31 115.19 13.29 22.50

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Mediterranean Towers has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Mediterranean Towers used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.
  • Mediterranean Towers has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Mediterranean Towers's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Mediterranean Towers has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

MDTW.F Health

 How is Mediterranean Towers's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Mediterranean Towers's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Mediterranean Towers's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Mediterranean Towers's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Mediterranean Towers's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Mediterranean Towers Company Filings, last reported 3 months ago.

OTCPK:MDTW.F Past Debt and Equity Data
Date (Data in ILS Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 933.81 420.93 243.24
2018-09-30 893.45 422.20 221.31
2018-06-30 876.59 424.34 187.45
2018-03-31 872.54 426.56 177.39
2017-12-31 906.10 431.08 195.45
2017-09-30 870.68 366.95 107.14
2017-06-30 832.66 424.57 114.43
2017-03-31 814.18 435.60 100.61
2016-12-31 839.79 446.92 121.91
2016-09-30 792.96 490.78 91.09
2016-06-30 780.78 464.73 90.37
2016-03-31 721.82 441.37 117.52
2015-12-31 729.56 471.99 182.16
2015-09-30 643.91 384.60 110.75
2015-06-30 640.38 383.95 108.95
2015-03-31 636.99 370.27 117.70
2014-12-31 609.39 403.21 153.77
2014-09-30 583.89 407.66 157.51
2014-06-30 612.09 336.19 211.96
2014-03-31 593.32 413.71 332.02
2013-12-31 522.73 259.30 44.15
2013-09-30 516.94 307.33 53.25
2012-12-31 421.16 272.47 39.01
  • Mediterranean Towers's level of debt (45.1%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (49.9% vs 45.1% today).
  • Debt is well covered by operating cash flow (39.7%, greater than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 0.4x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Mediterranean Towers's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Mediterranean Towers has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

MDTW.F Dividends

 What is Mediterranean Towers's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
2.51%
Current annual income from Mediterranean Towers dividends.
If you bought $2,000 of Mediterranean Towers shares you are expected to receive $50 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Mediterranean Towers's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.41%).
  • Mediterranean Towers's dividend is below the markets top 25% of dividend payers in United States of America (3.61%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:MDTW.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.6%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2008 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:MDTW.F Past Annualized Dividends Data
Date (Data in ₪) Dividend per share (annual) Avg. Yield (%)
2018-08-29 0.168 2.619
2018-05-30 0.266 4.197
2018-03-25 0.266 3.970
2017-08-24 0.280 4.180
2017-03-08 0.281 4.718
2016-05-31 0.200 3.905
2016-03-30 0.200 4.512
2014-11-30 0.421 9.346
2014-05-29 0.098 2.107
2014-03-27 0.098 1.987

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Mediterranean Towers has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Dividend payments have increased, but Mediterranean Towers only paid a dividend in the past 5 years.
Current Payout to shareholders
What portion of Mediterranean Towers's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.3x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Mediterranean Towers's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Mediterranean Towers afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Mediterranean Towers has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

MDTW.F Management

 What is the CEO of Mediterranean Towers's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Doron Arnon
COMPENSATION ₪2,068,000
TENURE AS CEO 15 years
CEO Bio

Mr. Doron Arnon has been the Chief Executive Officer of Mediterranean Towers Ltd. since April 01, 2004. Mr. Arnon holds Accounting degree from Ramat Gan College.

CEO Compensation
  • Doron's compensation has been consistent with company performance over the past year.
  • Doron's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure of the Mediterranean Towers management team in years:

8.2
Average Tenure
  • The average tenure for the Mediterranean Towers management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Doron Arnon

TITLE
Chief Executive Officer
COMPENSATION
₪2M
TENURE
15 yrs

Offir Rosenboim

TITLE
Deputy Chief Executive Officer and Chief Financial Officer
COMPENSATION
₪1M
TENURE
8 yrs

Tomer Rosenberg

TITLE
Vice President of Operating
COMPENSATION
₪1M
TENURE
8.3 yrs

Ronit Waissler Paz

TITLE
Vice President of Marketing and Sales
TENURE
4.3 yrs
Board of Directors Tenure

Average tenure and age of the Mediterranean Towers board of directors in years:

4.9
Average Tenure
61
Average Age
  • The tenure for the Mediterranean Towers board of directors is about average.
Board of Directors

Yair Seroussi

TITLE
Chairman of the Board
AGE
63
TENURE
1.8 yrs

Boris Levin

TITLE
Deputy Chairman of the Board of Directors
COMPENSATION
₪462K

Rafi Baeri

TITLE
Outside Director
TENURE
4.9 yrs

Moti Kirschenbaum

TITLE
Director
COMPENSATION
₪2M
TENURE
16.2 yrs

Gabriel Meir Lev

TITLE
Director
TENURE
6 yrs

Ran Grodecki

TITLE
Director
AGE
53
TENURE
6.3 yrs

Yossi Steinman

TITLE
Director
AGE
80
TENURE
6 yrs

Eynat Tsafrir

TITLE
Outside Director
AGE
52
TENURE
4.9 yrs

Erez Gissin

TITLE
Outside Director
AGE
59
TENURE
4.9 yrs

Zvi Forman

TITLE
Alternate Director
AGE
70
TENURE
4.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Mediterranean Towers's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Mediterranean Towers has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

MDTW.F News

Simply Wall St News

MDTW.F Company Info

Description

Mediterranean Towers Ltd. operates a chain of retirement communities in Israel. The company was founded in 1982 and is based in Bat Yam, Israel.

Details
Name: Mediterranean Towers Ltd.
MDTW.F
Exchange: OTCPK
Founded: 1982
₪268,761,486
143,297,897
Website: http://www.migdalei.co.il
Address: Mediterranean Towers Ltd.
Hayam 2,
Bat Yam,
Israel
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TASE MDTR Ordinary Shares The Tel-Aviv Stock Exchange IL ILS 11. Mar 2014
OTCPK MDTW.F Ordinary Shares Pink Sheets LLC US USD 11. Mar 2014
Number of employees
Current staff
Staff numbers
0
Mediterranean Towers employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/16 01:05
End of day share price update: 2019/01/16 00:00
Last earnings filing: 2019/03/18
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.